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Abstract
Neisseria gonorrhoeae, the bacterium responsible for the sexually transmitted disease gonorrhoea, has shown an extraordi-
nary ability to develop antimicrobial resistance (AMR) to multiple classes of antimicrobials. With no available vaccine, manag-
ing N. gonorrhoeae infections demands effective preventive measures, antibiotic treatment and epidemiological surveillance. 
The latter two are progressively being supported by the generation of whole- genome sequencing (WGS) data on behalf of 
national and international surveillance programmes. In this context, this study aims to perform N. gonorrhoeae clustering into 
genogroups based on WGS data, for enhanced prospective laboratory surveillance. Particularly, it aims to identify the major 
circulating WGS- genogroups in Europe and to establish a relationship between these and AMR. Ultimately, it enriches public 
databases by contributing with WGS data from Portuguese isolates spanning 15 years of surveillance. A total of 3791 carefully 
inspected N. gonorrhoeae genomes from isolates collected across Europe were analysed using a gene- by- gene approach (i.e. 
using cgMLST). Analysis of cluster composition and stability allowed the classification of isolates into a two- step hierarchi-
cal genogroup level determined by two allelic distance thresholds revealing cluster stability. Genogroup clustering in general 
agreed with available N. gonorrhoeae typing methods [i.e. MLST (multilocus sequence typing), NG- MAST (N. gonorrhoeae multi- 
antigen sequence typing) and PubMLST core- genome groups], highlighting the predominant genogroups circulating in Europe, 
and revealed that the vast majority of the genogroups present a dominant AMR profile. Additionally, a non- static gene- by- gene 
approach combined with a more discriminatory threshold for potential epidemiological linkage enabled us to match data with 
previous reports on outbreaks or transmission chains. In conclusion, this genogroup assignment allows a comprehensive 
analysis of N. gonorrhoeae genetic diversity and the identification of the WGS- based genogroups circulating in Europe, while 
facilitating the assessment (and continuous monitoring) of their frequency, geographical dispersion and potential association 
with specific AMR signatures. This strategy may benefit public- health actions through the prioritization of genogroups to be 
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DATA SUMMARY
All Neisseria gonorrhoeae reads generated in this study have 
been deposited in the European Nucleotide Archive (ENA) 
(BioProject accession no. PRJEB36482; www. ebi. ac. uk/ ena/ 
data/ view/ PRJEB36482). ENA sample accession numbers are 
included in Table S1 (available with the online version of this 
article). The read datasets used were downloaded from the ENA 
(BioProject accession numbers PRJEB14933, PRJEB2124, 
PRJEB23008, PRJEB26560, PRJEB9227, PRJNA275092, 
PRJNA348107, PRJNA473385, PRJNA315363) and all sample 
accession numbers are included in Table S2. Supplementary 
material for this study was deposited in ZENODO and is 
available at https:// doi. org/ 10. 5281/ zenodo. 3946223.
INTRODUCTION
The disease burden of gonorrhoea has increased in the last 
decade and remains a major public- health concern world-
wide. From 2012 up to 2016, the World Health Organization 
observed an increase from 78.3 to 87.0 million new cases 
per year of gonorrhoea worldwide [1, 2], with the Euro-
pean Centre for Disease Prevention and Control reporting 
around 90 000 notified cases in 2016 across 27 European 
Union/European Economic Area (EU/EEA) countries [3]. 
This sexually transmitted disease, caused by the bacterium 
Neisseria gonorrhoeae, usually affects the urogenital tract, 
causing urethritis in men and cervicitis in women, resulting 
in significant morbidity, but can also affect the anal canal 
and oropharyngeal tract causing proctitis and pharyngitis, 
respectively. Linked to disease burden, treatment strategies 
are being continuously challenged due to N. gonorrhoeae’s 
ability to acquire antimicrobial resistance (AMR) to multiple 
classes of antimicrobials, including β-lactams, tetracyclines, 
macrolides and quinolones, after the acquisition of genes or 
mutations conferring resistance [4–7]. During the last decade, 
there has been a steady rise in minimum inhibitory concen-
trations (MICs) for cephalosporins, with resistant strains and 
clinical failures being described [8–14]. A worldwide increase 
in azithromycin resistance is also being reported [15–19], 
with resistant strains being associated with recent outbreaks 
[20–22].
With these last lines of treatment seemingly failing, and the 
fear that gonorrhoea might become untreatable, reaching 
a ‘superbug’ status, the World Health Organization, the 
European Centre for Disease Prevention and Control, and 
the Centers for Disease Control and Prevention (CDC) 
have issued action plans since 2012, raising the awareness 
of health- care professionals to define and monitor treatment 
failures of gonorrhoea worldwide [5]. In the absence of a 
vaccine, the management of N. gonorrhoeae mainly relies 
on preventive measures, an effective antibiotic treatment 
and epidemiological surveillance. As such, whole- genome 
sequencing (WGS) data are now being generated in order 
to monitor global N. gonorrhoeae epidemiology and AMR 
trends, with several countries already performing WGS on 
behalf of national or international surveillance programmes 
[23]. Nevertheless, during the last few years, N. gonorrhoeae 
molecular epidemiology studies, using WGS data, have been 
mostly focused on the reporting of circulating genogroups 
defined by typing strategies relying on just a few genomic loci, 
namely the traditional two gene N. gonorrhoeae multi- antigen 
sequence typing (NG- MAST) scheme, the seven- loci- based 
multilocus sequence typing (MLST), and the seven- loci 
N. gonorrhoeae sequence typing for antimicrobial resistance 
(NG- STAR) [24]. This has been performed, for instance, to 
group isolates based on the most prevalent sequence types 
(STs) [6] or to cluster isolates based on allelic differences 
(ADs) of both NG- MAST genes [25, 26]. Therefore, these 
approaches do not take advantage of the full potential of 
using whole- genome data for typing as well demonstrated 
by the recent publication of insightful WGS- based studies 
relevant for the understanding of N. gonorrhoeae evolution 
[27], population structure [28] and transmission of AMR 
determinants [29]. Nevertheless, N. gonorrhoeae exhibits 
a non- clonal population structure [30], due to frequent 
intraspecies horizontal gene transfer, leading to the need for 
comprehensive identification and tracking of circulating line-
ages or genetic groups for this pathogen [27, 28]. Achieving 
this goal has been a recurring challenge in molecular epidemi-
ology due to the lack of approaches to quantitatively evaluate 
cluster stability and, therefore, identify genetic thresholds 
that define stable clusters representing main circulating 
lineages. In this context, the present study, focused on the 
European panorama (>3000 isolates from 21 countries), aims 
to perform WGS- based N. gonorrhoeae genogroup clustering 
for prospective WGS- based surveillance. Particularly, we 
aimed to identify the major circulating WGS- genogroups in 
Impact Statement
National and international surveillance programmes 
are increasingly promoting the application of genomic 
data to track the main circulating lineages of Neisseria 
gonorrhoeae, and the emergence and spread of antimi-
crobial resistance (AMR). Using data from 3791 isolates 
collected in Europe, we report a comprehensive whole- 
genome- sequencing- based genogroup assignment for 
N. gonorrhoeae, based on the identification of the 
maximum discriminatory genetic thresholds reflecting 
cluster stability. The genogroups defined at these levels, 
which represent the main circulating lineages, were 
correlated with other typing techniques and further 
linked to specific AMR signatures. Insights on the clus-
tering at a higher discriminatory level further supported 
the suitability of gene- by- gene typing strategies to 
detect/track outbreaks and transmission chains as a 
means to promote and/or support epidemiological inves-
tigation. This study enhances N. gonorrhoeae surveillance 
by promoting the prospective monitoring of genogroup 
frequency and geographical spread, towards more 
oriented public- health actions to control the spread of 
N. gonorrhoeae AMR.
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Europe, assess their geographical spread and search for poten-
tial relationships between particular genogroups and specific 
AMR signatures. To achieve this, we used a large dataset of 
European gonococcal sequences available in public datasets, 
now enriched with 600 additional isolates spanning fifteen 
years of N. gonorrhoeae surveillance in Portugal.
METHODS
Selection and characterization of Portuguese 
isolates
N. gonorrhoeae isolates analysed in the present study are part 
of the ongoing activity of the Portuguese National Laboratory 
Network for Neisseria gonorrhoeae Collection (PTGonoNet) 
hosted at the National Reference Laboratory for Sexually 
Transmitted Infections of the Portuguese National Institute 
of Health (NRL) [31]. Six hundred Portuguese isolates (herein 
designated as ‘PT isolates’) collected from 2003 up to 2017 
from distinct specimens, spread across the country, and 
presenting different antimicrobial- susceptibility profiles were 
selected for analysis. Regarding antimicrobial- susceptibility 
testing, MICs for azithromycin, benzylpenicillin, cefixime, 
ceftriaxone, ciprofloxacin, gentamicin, spectinomycin and 
tetracycline were determined by Etest (bioMérieux), as 
previously described [31]. For 117 isolates from 2006 up 
to 2010, no MIC values were available for some antibiotics, 
as antibiotic susceptibility was determined by agar dilution 
breakpoint technique at the time by Public Health England, 
which provided solely qualitative results [32] (Table S1). All 
but 65 isolates were tested for β-lactamase production using 
the chromogenic reagent Nitrocefin (Oxoid), according to the 
manufacturer’s instructions. Isolate antibiotic resistance was 
classified according to the current European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) breakpoint 
definitions [33]. From the 600 studied PT isolates, 491 isolates 
were subjected to WGS at the Portuguese National Institute 
of Health, and 109 isolates collected in 2013 were externally 
sequenced on behalf of the NRL participation in EURO- 
GASP (European Gonococcal Antimicrobial Surveillance 
Programme) [6]. Briefly, DNA was extracted from each isolate 
using the NucliSens easyMAG platform (bioMérieux) for 
total nucleic acid extraction, according to the manufacturer’s 
instructions. DNA was then subjected to Nextera XT library 
preparation (Illumina) prior to paired- end sequencing (2×250 
bp or 2×150 bp) on either a MiSeq or a NextSeq 550 instru-
ment (Illumina), according to the manufacturer’s instructions. 
Coded isolate designations, available anonymized metadata, 
antibiotic- susceptibility data and WGS details for all isolates 
are reported in Table S1.
Additional dataset for the European context and 
genome assembly
In order to obtain the current genetic diversity of N. gonor-
rhoeae circulating in European countries and to integrate the 
novel PT genomes in this global scenario, ultimately strength-
ening the analyses conducted in the present study, we took 
advantage of the public availability of 3263 genomes obtained 
from strains isolated in Europe. As such, WGS read datasets 
were download from the European Nucleotide Archive (ENA) 
from the following BioProjects: PRJEB14933 [20]; PRJEB2124 
[34]; PRJEB23008 [35]; PRJEB26560 [12]; PRJEB9227 [6]; 
PRJNA275092 [36]; PRJNA348107 [37]; PRJNA473385 [38]; 
PRJNA315363 [39]. Available data for the isolates used, 
including sample accession numbers, are detailed in Table S2.
All genome sequences were assembled using the INNUca 
v4.0.1 pipeline (https:// github. com/ B- UMMI/ INNUca), an 
integrative bioinformatics pipeline for read quality analysis 
and de novo genome assembly [40]. Briefly, read quality 
analysis and improvement is performed using FastQC 
v0.11.5 (http://www. bioinformatics. babraham. ac. uk/ projects/ 
fastqc/) and Trimmomatic v0.36 [41] (with sample- specific 
read trimming criteria determined automatically based on 
FastQC report), respectively. Genomes were assembled with 
SPAdes v3.11 [42] and subsequently polished using Pilon 
v1.18 [43], with Quality Assurance/Quality Control statistics 
being monitored and reported throughout the analysis. For all 
isolates, assembly statistics including final genome assembly 
sizes, number of contigs and mean depth of coverage values 
are reported in Tables S1 and S2. Only 28 out of the 3861 
genomes (2 PT and 26 publicly available genomes) were 
excluded after assembly, due to a genome size larger than 
expected, mean depth of coverage below 15× or the detection 
of contamination.
In silico typing and AMR prediction
For all validated assemblies, in silico seven loci MLST predic-
tion was performed using mlst v2.4 software (https:// github. 
com/ tseemann/ mlst), which is integrated within the INNUca 
pipeline. NG- MAST was performed using the ngmaster v0.4 
software [44], with novel alleles and STs being assigned after 
submission to the international database of the NG- MAST 
website (http://www. ng- mast. net/). Additionally, rplF fine- 
typing [45] was performed in order to confirm Neisseria 
species, upon query to the PubMLST Neisseria database 
(http:// pubmlst. org). Identification of AMR determinants 
in silico was performed using ariba v2.12.2 with the NG 
database [46], with all known variants analysed reported 
in Tables S1 and S2. Additional variants not classified in 
the ariba database as ‘known variants’ were also inspected 
[7, 47], namely: A39T and R44H in mtrR, 91K in parC and 
−35Adel in the mtrR promoter. We also performed isolate 
typing with NG- STAR [24], upon query to the PubMLST 
Neisseria database, for interpretation purposes. The results 
of this study were oriented towards the results provided by 
ariba, as it provides the ability to inspect more loci and, more 
importantly, variants that are carried heterogeneously.
Gene-by-gene analysis
Gene- by- gene analysis was performed by taking advantage of 
the publicly available panel of 1649 loci from the PubMLST 
Neisseria database (N. gonorrhoeae cgMLST v1.0 [28], avail-
able at http:// pubmlst. org), which was prepared in the present 
study for the chewBBACA core suite v2.0.11 [48] using the 
PrepExternalSchema module. This was a quality- control step 
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to ensure that all loci are coding sequences as required by 
chewBBACA. Allele calling was performed on all assemblies 
using chewBBACA, with minimum blast score ratio to 
0.6 and size threshold adjusted to 0.3 (i.e. alleles with size 
variation of 30 % to be tagged), and a training file generated 
by Prodigal v2.6.3 using the reference genome NCCP11945 
(RefSeq accession number NC_011035). After inspection, 
the scheme was additionally curated by removing 16 loci that 
were flagged as ‘repeated loci’ after allele calling and another 
39 loci that were only successfully called in less than 1 % of 
the genomes (Table S3). Exact and inferred matches were used 
to construct an allelic profile matrix, where other allelic clas-
sifications (see https:// github. com/ B- UMMI/ chewBBACA/ 
wiki) were assumed as ‘missing’ loci. Assemblies with less 
than 1545 loci called (~97 %) in the scheme were removed, 
which occurred only for 44 assemblies (19 PT and 25 publicly 
available) under analysis (detailed in Tables S1 and S2). Of 
note, the application of a more stringent cut- off was meant to 
increase confidence in the cluster stability analysis, although 
a lower cut- off (namely a ‘traditional’ 95% loci called) can be 
applied with this adapted scheme.
WGS-based genogroup classification
For WGS- based surveillance purposes, N. gonorrhoeae 
isolates were classified into two- step hierarchical WGS- 
based genogroups. For this, we used the maximum- shared 
loci of the PubMLST cgMLST scheme at 100 % by all 3791 
validated genomes (upon assembly- and cgMLST- based 
exclusion), which resulted in 822 loci [herein designated as 
the maximum- shared cgMLST (MScgMLST) scheme; Table 
S4]. From the allelic profile matrix, the goeBURST algorithm 
[49, 50] implemented in the PHYLOViZ software [51] 
was used to generate clusters at all possible allelic distance 
thresholds [here expressed as the number of ADs over the 
total number of loci under analysis]. Cluster concordance 
was then assessed by the neighbourhood adjusted Wallace 
coefficient (nAWC), where all clusters partitioning at adjacent 
allelic distance thresholds (i.e. cut- off for ADs n and n+1) 
were compared using the  comparing_ partitions. py script 
(https:// github. com/ jacarrico/ ComparingPartitions) [52, 53], 
as previously described [40, 54]. Following this, we searched 
for consecutive goeBURST thresholds over which cluster 
congruence is high (i.e. nAWC plateaus reflecting cluster 
stability) as a mean to define thresholds (or threshold ranges) 
useful for longitudinal surveillance, i.e. stable genogroups that 
represent major circulating lineages [40, 54]. Two stability 
phases, defined as the first and second intervals at which 
five or more consecutive thresholds yielded nAWC above 
0.99, were used to cluster isolates into low- and high- level 
WGS- based genogroups, respectively. Each isolate was then 
classified into a specific genogroup designated as ‘GX.Y’, 
where X and Y are non- redundant arbitrary three digit 
numbers associated, respectively, to the high- and low- level 
WGS- based genogroup clustering, i.e. constituting two- step 
hierarchical genogroup definition directly associated with the 
two determined allelic distance thresholds. We further identi-
fied the goeBURST threshold ranges with the highest typing 
concordance with MLST and NG- MAST classifications using 
the adjusted Rand index (ARI) and adjusted Wallace coef-
ficient (AWC) [52, 53]. Using the same rationale, cluster 
composition at both threshold levels defining WGS- based 
genogroups were compared with cluster composition defined 
by NG- MAST and MLST, where the Shannon index (SI) was 
used to measure cluster entropy with each partition. This was 
also performed to compare cluster composition between the 
MScgMLST scheme and the maximum shared loci obtained 
when using the cgMLST typing directly on the PubMLST 
website (i.e. 537 loci), with comparison only performed for 
the 1977 isolates where allelic profiles were available.
N. gonorrhoeae genogroups and genetic clustering 
analysis
A gene- by- gene allelic profile matrix was used to construct 
a minimum spanning tree (MST) using the goeBURST 
algorithm [50] implemented in the PHYLOViZ online 
web- based tool [51] based on 100 % shared loci between all 
isolates [49]. To take advantage of the maximum number of 
loci from the scheme (which may be key for discriminating 
potential epidemiological clusters), we used PHYLOViZ 
online 2.0 beta version (http:// online2. phyloviz. net/), which 
allows maximizing the shared genome in a dynamic manner 
[40, 55]. As such, for each subset of isolates under compar-
ison, the maximum number of shared loci between them 
is automatically used for MST construction. AD thresholds 
for cluster inspection are expressed as percentages of AD 
over the total number of shared loci under comparison 
for every analysis of each subset of isolates at any given 
level. As there is no established cut- off range for N. gonor-
rhoeae outbreak detection and contact tracing, we applied 
a conservative approach to investigate (and characterize 
at AMR level) sub- clusters with potential epidemiological 
links. In summary, after generating a sub- MST for each low- 
level genogroup, we applied a cut- off of 1.5 % AD, which 
represents half of the mean percentage of AD observed 
within each low- level genogroup of the full dataset.
Data availability
All reads generated for the present study were deposited in the 
ENA under the study accession number PRJEB36482 (indi-
vidual run accession numbers are detailed in Table S1). The 
PubMLST N. gonorrhoeae cgMLST v1 scheme adapted for 
chewBBACA [48], the MScgMLST scheme, as well as allelic 
profile matrix for both schemes are available at https:// doi. 
org/ 10. 5281/ zenodo. 3946223. Additionally, a .json file also 
has been made available for direct upload into the GrapeTree 
visualization software [56] in order to interactively explore 
data/metadata.
RESULTS
N. gonorrhoeae WGS-based genogroups
In the present study, 3791 N. gonorrhoeae genomes from 
isolates collected across Europe (21 EU/EEA countries) 
were analysed using the PubMLST N. gonorrhoeae cgMLST 
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scheme. This scheme, enrolling 1594 loci, yielded 3623 
unique allelic profiles (including loci not called). In order 
to determine WGS- based genogroups for long- term and 
large- scale surveillance, a shorter scheme was used, based 
on the loci shared (i.e. called) by all isolates. This scheme 
comprising 822 loci (Table S4) yielded 2422 unique allelic 
profiles (see Supplementary Material). After clustering 
using goeBURST, cluster composition was compared at all 
possible allelic distance thresholds using the nAWC (Fig. 
S1). Results showed that the two earliest cluster stability 
points are at 40 ADs (4.87 %; low- level) and at 79 ADs 
(9.61 %; high- level). Subsequently, we defined WGS- based 
genogroups at two- step hierarchical clustering levels taking 
into account these two thresholds. This assignment allows 
a comprehensive analysis of N. gonorrhoeae genetic diver-
sity and the identification of the WGS- based genogroups 
circulating in Europe, while facilitating the assessment (and 
continuous monitoring) of their frequency, geographical 
dispersion and potential association with specific AMR 
signatures. As such, we sought to assess the weight of each 
genogroup (at both high- and low- levels) in the whole 
dataset. The low- level stability point (i.e. more discrimina-
tory) yielded 321 clusters, of which 208 are represented by 
one or two isolates and 38 by more than ten isolates, while 
the high- level cut- off yielded 180 clusters, of which 106 
are composed by one or two isolates and 35 by more than 
ten isolates. A total of 35 high- level (Table 1) and 38 low- 
level genogroups (Table 2) composed of at least ten isolates 
comprise 91.6 and 84.4 % of the whole dataset analysed, 
respectively. Thus, we opted to perform all downstream 
analysis focusing particularly on these more represented 
genogroups. The mean allelic diversity within low- level 
genogroups composed of at least 10 isolates was of ~3 % 
(AD=25), ranging from 0.2 (AD=2) up to 8.5 % (AD=70) 
(Fig. S2), while for high- level genogroups it was ~5 % 
(AD=41), ranging from 0.2 up to 10.7 % (AD=88). When 
the number of shared loci was maximized within each 
genogroup (mean of 1.8- fold increase for all genogroups), 
the mean allelic diversity for low- level was observed at 
3.5 %, ranging from 0.2 up to 9.9 % (AD=81), and 5.3  % 
for high- level, ranging from 0.2 up to 12.4 % (AD=102). 
These results suggest that diversity within each WGS- based 
genogroups remains similar when the number of loci under 
comparison is increased (i.e. when the number of shared 
loci approaches the entire cgMLST scheme), and that the 
typing resolution (i.e. degree of genetic relatedness between 
isolates) is not compromised by using the MScgMLST 
scheme. For instance, for genogroup G001.002, composed 
by 491 isolates, when the number of shared loci under 
analysis increased from 822 to 1408, the mean AD only 
increased from 4.12 to 4.76 %.
From traditional to WGS-based typing
We then compared the relationship between the novel 
defined WGS- genogroups and the isolates’ classification 
based on traditional typing methods for N. gonorrhoeae 
(Fig.  1), namely MLST (which yielded ~180 profiles; 
SI=5.136) and NG- MAST (which yielded ~800 profiles; SI 
7.431). Cluster congruence analysis between MLST types 
and WGS- genogroups showed that overall cluster congru-
ence is slightly higher with the low- level WGS- genogroups 
than with the high- level (ARI=0.584 and 0.524, respec-
tively). Nevertheless, the greater cluster agreement between 
MLST and WGS- genogroups was observed at the high level, 
as we observed a 64.2 % probability of isolates belonging to 
the same MLST type to also belong to the same high- level 
genogroup, and a probability of 54.6 % when evaluating 
the low- level (based on AWC analysis). The goeBURST 
threshold range that displayed simultaneously higher 
concordance and agreement with MLST was between 15.9 
and 24.9 % AD (i.e. 131 and 205 ADs), where the highest 
AWCs were observed (between 0.660 and 0.663) with 
ARI values above 0.520 (up to 0.529) (Fig. S3). Regarding 
NG- MAST typing, we observed that the goeBURST 
threshold range that displayed higher congruence and 
agreement was between 4.4 and 6.8 % AD (i.e. 36 and 56 
ADs). When compared with MLST analysis, this lower 
threshold range could be explained by a higher number 
of profiles observed in NG- MAST clustering. Neverthe-
less, although the results showed that the level of entropy 
in NG- MAST clustering is higher than with the other 
methods, the probability that a set of strains evidencing 
the same NG- MAST also belong to the same high- and 
low- level genogroups was very high (AWC of 0.979 and 
0.887, respectively). This overall trend is especially relevant 
for abundant genogroups (Fig. 1, Tables 1 and 2), as there 
is a strong correspondence between particular MLST and 
NG- MAST types and high- and low- level genogroups. 
For example, all 52 isolates from genogroup G025.030 are 
from MLST ST1893 and NG- MAST ST8517. In contrast, 
isolates from genogroup G006.007 are from MLST ST1579, 
but present 25 distinct ST in NG- MAST typing (Table 2). 
Additionally, comparison with PubMLST website results 
for 1977 isolates (discriminated in Table S2) showed that 
cluster congruence was high with the novel defined WGS- 
genogroups, as ARI values were equal to 0.815 and 0.931 
when cluster composition was compared at the high and 
low- level thresholds, respectively. Furthermore, we also 
compared the recently proposed core- genome groups [28], 
defined at 400 locus differences threshold (Ng_cgc_400) 
using the PubMLST cgMLST scheme, for 1830 isolates 
for which data were available (discriminated in Table S2) 
and were present in our dataset (Fig. S4). We observed the 
Ng_cgc_400 groups have a less discriminatory resolution 
than the two- stable- level WGS- based genogroup defined 
in the present study (Fig. S4b). More importantly, results 
showed that when the same cut- off of ~24 % (i.e. 400 ADs 
in the 1649 loci PubMLST scheme and 199 ADs in the 822 
loci MScgMLST scheme) is applied to our data, there is a 
remarkable agreement between isolate grouping (Fig. S4a), 
reinforcing that our threshold might be scaled to the entire 
scheme while keeping the robustness of the clustering. In 
summary, the novel defined genogroups correlated well 
with MLST and NG- MAST classification, which largely 
facilitates backwards compatibility in the transition to 
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with at least 
five isolates
G001 9363 (38.2) 1580 (18.6) 2992 (40.1) 9768 (7.0) 63 (42.6) 301 (8.0) 817 20 2003–2017 15
G002 1901 (82.8) 1579 (6.3) 1407 (48.8) 2212 (3.0) 90 (72.5) 89 (2.3) 574 20 2004–2017 19
G005 1901 (98.5) 11992 (0.4) 225 (67.2) 5967 (3.6) 26 (70.4) 310 (6.9) 274 15 2004–2017 5
G004 7363 (97.6) 1587 (1.4) 2400 (55.9) 6360 (14.2) 158 (74.9) 419 (9.0) 211 17 2010–2017 8
G003 11990 (60.4) 1594 (35.6) 51 (35.1) 25 (34.2) 20 (59.4) 722 (9.4) 202 10 2005–2017 4
G006 1579 (100.0) – 21 (32.0) 1034 (19.3) 139 (94.7) 856 (2.0) 150 13 2004–2017 7
G007 1918 (99.3) 10305 (0.7) 12 (57.3) 44 (32.9) 239 (89.5) 1510 (10.5) 143 1 1995–2014 1
G010 1584 (86.6) 11172 (9.0) 26 (62.7) 4528 (11.2) 178 (89.6) 410 (3.0) 134 7 2002–2016 3
G012 8122 (100.0) – 292 (75.2) 210 (21.7) 299 (76.7) 85 (19.4) 129 6 2003–2015 3
G009 7822 (95.0) 11985 (1.7) 4995 (67.2) 10421 (19.3) 416 (89.1) 72 (2.5) 119 11 2012–2017 3
G008 1588 (76.7) 11247 (13.3) 3785 (11.1) 1582 (8.9) 247 (18.9) 870 (13.3) 90 16 2005–2017 6
G011 11 516 (95.0) 11 980 (5.0) 1780 (58.8) 5793 (16.3) 56 (67.5) 55 (27.5) 80 6 2008–2016 2
G014 8143 (96.7) 11968 (1.6) 5624 (45.9) 9918 (34.4) 426 (42.6) 436 (36.1) 61 13 2012–2017 4
G025 1893 (100.0) – 8517 (92.9) 5993 (3.6) 142 (100.0) – 56 3 2011–2016 1
G013 1582 (72.2) 11727 (13.0) 147 (24.1) 2997 (9.3) 186 (72.2) 896 (7.4) 54 9 2003–2014 3
G018 1596 (100.0) – 384 (40.5) 190 (19.0) 955 (66.7) 307 (26.2) 42 4 2003–2014 1
G019 1588 (100.0) – 1479 (40.5) 19083 (40.5) 271 (48.6) 433 (48.6) 37 5 2005–2017 2
G015 8135 (97.1) 11997 (2.9) 987 (55.9) 5120 (17.6) 729 (94.1) New (2.9) 34 10 2013–2017 3
G016 1599 (68.8) ~1599 (31.3) 645 (62.5) 11461 (25.0) 520 (100.0) – 32 4 2013–2017 3
G017 8163 (58.6) 11975 (31.0) 2 (65.5) 226 (10.3) 84 (86.2) 424 (6.9) 29 7 2005–2015 2
G020 7826 (57.1) 7359 (42.9) 2487 (57.1) 4186 (19.0) 992 (57.1) 231 (38.1) 21 6 2008–2016 1
G021 8156 (100.0) – 5441 (68.4) 13489 (10.5) 442 (84.2) 982 (5.3) 19 8 2013–2017 1
G022 1892 (100.0) – 6129 (36.8) 387 (26.3) 563 (94.7) 867 (5.3) 19 5 2008–2013 1
G027 7827 (86.7) 13489 (6.7) 2318 (20.0) 8845 (13.3) 38 (46.7) 1225 (13.3) 15 4 2013–2017 1
G039 8776 (100.0) – 1285 (100.0) – 950 (100.0) – 15 4 2012–2014 1
G023 11986 (100.0) – 8465 (85.7) 26 (7.1) 162 (85.7) 432 (7.1) 14 2 2012–2015 1
G029 1588 (100.0) – 10801 (42.9) 11575 (42.9) 969 (50.0) 970 (21.4) 14 2 2013 2
G024 10932 (76.9) 11967 (15.4) 5004 (15.4) 4234 (15.4) 169 (46.2) 388 (30.8) 13 5 2008–2014 1
G031 11 956 (91.7) 8130 (8.3) New (83.3) 7414 (16.7) 2005 (83.3) 949(16.7) 12 3 2013–2015 1
G026 7367 (91.7) 1579 (8.3) 40 (16.7) 18167 (16.7) New (33.3) 733 (25.0) 12 2 2003–2009 1
G030 1590 (100.0) – 684 (45.5) 5519 (18.2) 1559 (45.5) 190 (27.3) 11 2 2004–2013 1
G041 11177 (100.0) – 1993 (100.0) – 568 (100.0) – 11 1 2013 1
G032 1585 (100.0) – 471 (60.0) 752 (20.0) 153 (80.0) 913 (20.0) 10 3 2004–2013 1
G028 8112 (100.0) – 8149 (40.0) 5560 (20.0) 352 (60.0) 468 (40.0) 10 2 2008–2017 1
G036 8114 (100.0) – 4 (40.0) ~69 (30.0) 46 (100.0) – 10 1 2004–2011 1
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No. of enrolled 
countries with 
at least five 
isolates
G002.001 1901 (83.9) 1579 (6.6) 1407 (55.8) 2212 (3.4) 90 (82.7) 951 (2.6) 502 20 2007–2017 18
G001.002 9363 (52.7) 11428 (19.0) 2992 (58.5) 3935 (8.8) 63 (69.7) 67 (7.7) 491 19 2009–2017 14
G005.004 1901 (99.0) 11992 (0.4) 225 (67.4) 5967 (3.7) 26 (70.7) 310 (7.0) 273 15 2004–2014 5
G004.003 7363 (97.6) 1587 (1.4) 2400 (56.2) 6360 (14.3) 158 (79.5) 419 (8.6) 210 17 2010–2017 8
G006.007 1579 (100.0) – 21 (32.0) 1034 (19.3) 139 (94.7) 856 (2.0) 150 13 2004–2017 7
G001.005 1580 (77.0) 8126 (19.6) 9768 (38.5) 359 (18.2) 1996 (34.5) 192 (27.7) 148 7 2003–2017 4
G007.008 1918 (99.2) 10305 (0.8) 12 (62.1) 44 (35.6) 239 (88.6) 1510 (11.4) 132 1 1995–2000 1
G003.006 11 990 (93.1) 1594 (4.6) 25 (46.6) 51 (43.5) 20 (65.6) 722 (14.5) 131 5 2008–2017 1
G012.013 8122 (100.0) – 292 (75.2) 210 (21.7) 299 (76.7) 85 (19.4) 129 6 2003–2015 3
G009.009 7822 (95.0) 11985 (1.7) 4995 (67.2) 10421 (19.3) 416 (89.1) 72 (2.5) 119 11 2012–2017 3
G010.010 1584 (88.1) 11172 (10.2) 26 (70.3) 4528 (12.7) 178 (95.8) 423 (1.7) 118 5 2002–2015 2
G011.011 11516 (95.0) 11980 (5.0) 1780 (58.8) 5793 (16.3) 56 (67.5) 902 (3.8) 80 6 2008–2016 2
G008.012 1588 (80.0) 11247 (20.0) 3785 (16.7) 1582 (13.3) 247 (23.3) 567 (13.3) 60 16 2005–2017 3
G001.015 1580 (59.0) 11999 (39.3) 995 (64.3) 1313 (10.7) 301 (42.9) 245 (42.9) 56 6 2005–2014 2
G025.030 1893 (100.0) – 8517 (100.0) – 142 (100.0) – 52 3 2013–2016 1
G001.024 11864 (98.0) 12521(2.0) 2992 (78.4) ~5230 (9.8) 439 (86.3) 453 (9.8) 51 3 2013–2015 1
G001.014 9363 (100.0) – 7445 (76.6) 11500 (6.4) 301 (70.2) 965 (10.6) 47 5 2013–2017 1
G019.022 1588 (100.0) – 1479 (41.7) 19083 (41.7) 433 (50.0) 271 (47.2) 36 5 2005–2014 2
G015.016 8135 (97.1) 11997 (2.9) 987 (55.9) 5120 (17.6) 729 (94.1) ~729 (2.9) 34 10 2013–2017 3
G002.017 1901 (91.2) 11107(8.8) 3150 (14.7) 2018 (14.7) 127 (23.5) 150 (17.6) 34 7 2004–2017 2
G016.018 1599 (68.8) ~1599 (31.3) 645 (62.5) 11461 (25.0) 520 (100.0) – 32 4 2013–2017 3
G014.020 8143 (96.7) 11971 (3.3) 5624 (93.3) 1691 (3.3) 426 (86.7) 890 (6.7) 30 9 2012–2017 3
G013.021 1582 (100.0) – 147 (36.7) 2997 (16.7) 186 (66.7) 752 (10) 30 5 2003–2013 3
G018.025 1596 (100.0) – 384 (56.7) 190 (26.7) 955 (93.3) 307 (6.7) 30 3 2003–2014 1
G017.019 8163 (55.6) 11975 (33.3) 2 (70.4) 226 (7.4) 84 (85.2) 424 (7.4) 27 7 2005–2015 2
G003.023 1594 (100.0) – 51 (63.6) 8148 (22.7) 851 (77.3) 2014 (13.6) 22 2 2005–2017 1
G014.038 8143 (100.0) – 9918 (95.5) 15909 (4.5) 436 (100.0) – 22 2 2014–2017 1
G003.036 1594 (100.0) – 10800 (68.4) 11042 (31.6) 20 (100.0) – 19 3 2013 2
G021.029 8156 (100.0) – 5441 (72.2) 13489 (11.1) 442 (88.9) New (5.6) 18 7 2013–2017 1
G008.026 1588 (100.0) – 3307 (43.8) 9171 (12.5) 249 (37.5) 53 (25) 16 6 2009–2013 1
G039.037 8776 (100.0) – 1285 (100.0) – 950 (100.0) – 15 4 2012–2014 1
G023.027 11986 (100.0) – 8465 (85.7) 26 (7.1) 162 (85.7) 432 (7.1) 14 2 2012–2015 1
G029.032 1588 (100.0) – 10801 (42.9) 11575 (42.9) 969 (50.0) 970 (21.4) 14 2 2013 2
G013.028 11727 (53.8) 7363 (46.2) 1466 (30.8) 4333 (23.1) 186 (84.6) 1347 (7.7) 13 1 2005–2009 1
G020.031 7826 (100.0) – 2487 (100.0) – 992 (100.0) – 12 3 2008–2013 1
G041.040 11177 (100.0) – 1993 (100.0) – 568 (100.0) – 11 1 2013 1
G031.044 11956 (90.0) 8130 (10.0) New (100.0) – 2005 (100.0) – 10 1 2014–2015 1
G036.034 8114 (100.0) – 4 (40.0) ~69 (30.0) 46 (100.0) – 10 1 2004–2011 1
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WGS- based typing, as associations between ST and AMR 
profiles have been previously reported [6].
Distribution of N. gonorrhoeae genogroups by 
European country
All novel PT isolates were integrated within a dataset of publicly 
available N. gonorrhoeae genomes, in order to assess their 
genomic diversity and phylogenetic relationships within the 
European circulating strains. As it stands, the dataset is highly 
represented by isolates from the UK (n=2263) and Portugal 
(n=579) in comparison with other European countries, some 
of which have less than ten isolates sequenced at the date of 
the analysis (e.g. Iceland and Cyprus). Global phylogenetic 
analysis, based on the MScgMLST scheme, revealed that the 
PT isolates presented high genetic diversity, being dispersed 
within the European genomic panorama (Fig. 2). PT isolates 
belonged to 115 distinct WGS- based genogroups, of which 32 
were mainly (>50 %) constituted by PT isolates (e.g. G001.014, 
G016.018 and G013.028) and 60 contained a single isolate. 
This is a reflection of N. gonorrhoeae’s global genetic diversity, 
as a total of 161 low- level genogroups were represented by a 
single isolate, and 81 genogroups were composed by isolates 
from a single country (Fig. S5), for example, G007.008 
(UK), G013.028 (PT), G041.40 (Denmark), G031.044 (UK), 
G036.034 (UK), G046.056 (Greece), G053.086 (Slovenia), 
G170.243 (Latvia) and G002.050 (PT). Results showed that 
the more geographically widespread and abundant high- level 
genogroups were G001 and G002, enrolling strains from 
20 countries, followed by G004, G008 and G005 enrolling 
isolates from 17, 16 and 15 countries, respectively (Table 1, 
Fig. 2). Even when fragmented into low- level genogroups, 
these were still within the more prevalent genogroups. In 
Fig. 1. Comparison of WGS- based genogroups, defined at two levels, and both traditional typing methods for N. gonorrhoeae. The MSTs 
enrol all 3791 N. gonorrhoeae isolates based on the MScgMLST scheme (822 loci). Nodes, corresponding to a unique allelic profile, 
are coloured according to their corresponding (a) high- level WGS- based genogroup, (b) low- level WGS- based genogroup, (c) ST of the 
traditional seven loci MLST scheme and (d) ST of the two loci NG- MAST scheme. Numbers in parenthesis refer to the number of isolates 
comprising each genogroup or ST. The MSTs were generated using GrapeTree v1.5.0 software [56].
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Fig. 2. Phylogeny of 3791 N. gonorrhoeae isolates from Europe, based on a gene- by- gene approach using the MScgMLST scheme. The 
MST was constructed based on allelic diversity found among the 822 genes shared by 100 % of the isolates. All nodes (which represent a 
unique allelic profile) presenting an allelic distance below 40, corresponding to the low- level genogroup threshold, have been collapsed 
for visualization purposes. Nodes are coloured according to different countries of origin. Straight and dotted lines reflect nodes linked 
with the allelic distances below and above the threshold applied for high- level WGS- based genogroup definition (allelic distance 79), 
respectively. Low- level WGS- based genogroups comprised more than ten isolates are highlighted by thicker black circles. The MST was 
generated using GrapeTree v1.5.0 software [56].
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fact, 11 low- level genogroups were represented by isolates 
of at least six countries, of which three were composed by 
at least five isolates, namely G002.001 (NG- MAST ST1407), 
G001.002 (ST2992), G005.004 (ST225), G004.003 (ST2400), 
G006.007 (ST21), G001.005 (ST9768), G012.013 (ST292), 
G009.009 (ST4995), G008.012 (ST3785), G015.016 (ST977) 
and G014.020 (ST5624), with isolates being detected with 
time intervals of 5 up to 14 years apart (Table 2).
WGS-based genogroups carrying antibiotic-
resistance determinants
We analysed 32 genetic determinants known to be involved 
in decreased susceptibility and resistance to antimicrobials in 
N. gonorrhoeae (namely for penicillin, tetracycline, cipro-
floxacin, azithromycin, cephalosporins, spectinomycin, 
sulphonamides and rifampicin), in order to assess their rela-
tionship with WGS- based genogroups at high- and low- levels 
(Fig. 3). Overall, results showed two distinct sets of isolates 
displaying a contrasting pattern of AMR, i.e. one with isolates 
carrying several genetic determinants related with decreased 
susceptibility and resistance (set A) and another with more 
susceptible isolates (set B). In fact, 15 out of 19 high- level geno-
groups from set A contained isolates independently resistant 
to at least four distinct antimicrobial drugs, contrasting with 
only 1 out of 16 high- level genogroups from set B (Fig. 3a). 
The same trend was observed at the low- level, with 19 out of 
24 genogroups from set A and only 1 out of 14 genogroups 
from set B (Fig. 3b). In order to understand whether these 
resistant markers were carried together by the same isolates 
(i.e. multidrug resistance), we analysed the most dominant 
AMR profiles observed within each low- level genogroup 
(Fig. 4), as well as the dominant NG- STAR ST (Table 2). We 
observed that for nine genogroups all isolates displayed the 
same specific AMR profile. Furthermore, results showed that 
there were 21 genogroups where the most dominant AMR 
profile was not the one exhibiting the largest repertoire of 
AMR determinants. In contrast, for eight genogroups, the 
dominant AMR profile was the one associated with more 
AMR determinants. Several scenarios can justify both obser-
vations, but sampling bias hampers a more in depth analysis 
of the evolutionary and epidemiological trajectory of the 
involved genogroups.
Regarding specific genetic alterations, for both genogroup 
levels, resistance to ciprofloxacin was only observed in set 
A (with exception of one set B G012 resistant isolate from 
2013), with all isolates from five different high- level geno-
groups simultaneously harbouring the resistance- mediating 
91F and 95G amino acids in DNA- gyrase subunit A (encoded 
by gyrA; NG- STAR allele 1), and eight others displaying at 
least one of them. The same trend was observed for five 
mutations in the topoisomerase IV subunit C- encoding gene 
parC associated with decreased susceptibility to quinolones, 
which were exclusive of set A isolates (albeit dissimilarly 
spread across distinct high- level genogroups) (Fig. 3a). At 
the low- level (Fig.  3b), 15 genogroups were almost fully 
composed by ciprofloxacin- resistant isolates, with two 
others having only a few resistant isolates (G001.002 with 
15 isolates from 2013 to 2015 and G001.0015 with one 
isolate from 2013). Amino acid alteration 553 N in the 
RNA polymerase subunit B (rpoB), conferring resistance to 
rifampicin [47], was exclusively observed in set A. Likewise, 
the azithromycin resistance- associated mutation C2597T in 
23S rRNA was mostly observed in nine genogroups of set 
A. Furthermore, only isolates from high- level genogroup 
G001 (Fig.  3a) carried the mutation A2045G (NG- STAR 
allele 1), conferring high- level resistance to azithromycin. 
More importantly, this seemed to be exclusive to low- level 
genogroups G001.005 and G001.002 (Fig. 3b), with isolates 
having a fixed mutation (i.e. present in all 23S rRNA copies) 
or carrying it heterogeneously. Spectinomycin- resistance- 
associated mutation in 16S rRNA was only observed in one 
isolate from Sweden (G001.002) carrying it heterogeneously. 
Furthermore, resistance- associated markers for sulphona-
mides (dihydropteroate synthase- encoding gene folP), tetra-
cycline (presence of the tetM- carrying conjugative plasmid) 
and penicillin (presence of the blaTEM plasmid, associated 
with β-lactamase production) were widespread across most 
of the genogroups. All markers seemed to be more frequent 
in genogroups from set A. For instance, all of them carried 
the mutation 228S in folP, while blaTEM and tetM were not 
found in only three and four high- level genogroups, respec-
tively (Fig. 3a). Regarding the putative resistance to cepha-
losporins, results showed that most isolates from G002.001 
(494 out of 502, ranging from 2007 to 2017) simultaneously 
possessed the three mutations (i.e. 312M, 316T and 545S) 
in the penicillin- binding protein 2- encoding gene (penA) 
that are known to potentially mediate resistance [6, 57], 
97.0 % of which precisely carry the mosaic penA- XXXIV 
allele (NG- STAR allele 266, mostly associated with ST90) 
[58]. Besides G002.001 isolates, this mutational profile was 
only detected in 24 other isolates in the whole dataset (from 
2013 to 2016, representing eight different genogroups). The 
whole penA- XXXIV allele was observed in 12 out these 24 
isolates, which is suggestive of acquisition by recombina-
tion. Of note, other mutations in penA (inducing decreased 
susceptibility to penicillins and cephalosporins) were only 
observed in set A isolates. Concerning genetic markers 
associated with decreased susceptibility to penicillin, the 
mutation 421P in the penicillin- binding protein 1- encoding 
gene (ponA) was exclusively present in set A genogroups 
(Fig. 3); this mutation was carried by >90 % of isolates from 
14 distinct low- level genogroups. Three mutations associated 
with decreased susceptibility to penicillins, cephalosporins 
and tetracycline, targeting the major porin- encoding gene 
porB (type porB1b), were observed in 1590 isolates from set 
A, contrasting with only 26 isolates from set B. Likewise, 
genetic alterations in the MtrR transcriptional regulator 
or its promoter, disrupting the MtrCDE efflux of substrate 
antimicrobials, were also mainly observed in set A. Of note, 
mutation A39T in mtrR was observed in most genogroups, 
but the combination of mutations A39T and R44H, associ-
ated with decreased susceptibility [59, 60], was only observed 
in G001 and G036. Finally, it is noteworthy that our data 
suggests that genogroups G007, G022, G032 and G041 were 
susceptible to all antimicrobials.
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Fig. 3. Heatmap distribution and occurrence of the genetic determinants involved in AMR by high- level (a) and low- level (b) WGS- 
based genogroups. Genetic determinants are ordered by the affected antimicrobial drug class/antibiotic, with resistance or decreased 
susceptibility effect described at the bottom. Heatmap colour range correlates with the percentage of isolates carrying each genetic 
determinant within a given WGS- based genogroup. The numbers of isolates within each genogroup are presented on the right of each 
panel. The contextual neighbour- joining phylogenetic tree at the left side of each panel was generated based on the MScgMLST allelic 
profiles using GrapeTree v1.5.0 software [56]. The asterisk indicates that the combination of these three mutations has been proposed 
as potentially inducing resistance to cephalosporins [8]. AZM, Azithromycin; CFM, cefixime; CIP, ciprofloxacin; CRO, ceftriaxone; PEN, 
penicillins; RI, rifampicin; SPT, spectinomycin, SUL, sulphonamides; TET, tetracycline.
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Association between N. gonorrhoeae genetic 
clustering and epidemiological data
In order to analyse genetic clusters with the potential to be 
epidemiologically linked, we applied a conservative threshold 
of 1.5 % AD within each low- level genogroup, after sub- MST 
generation maximizing the shared loci between isolates at 
this level. As such, we observed a total of 315 genetic clus-
ters spread out across 141 low- level genogroups. Results are 
presented for all clusters composed of more than ten isolates 
(Fig. 5a), with the phylogenetic distribution of all identified 
clusters with ≥5 isolates presented in Fig. 5(b) (full detailed 
data described in Tables S1 and S2). Expectedly, the more 
prevalent low- level genogroups presented the highest number 
of genetic clusters, namely G001.002, G002.001, G005.004 
and G001.005 (Fig. 5b). Nevertheless, we also observed cases 
where a single large close- related genetic cluster was detected 
within a given genogroup (e.g. G023.027, G021.029, G041.040 
and G001.014; see Fig.  5b). In another perspective, this 
Fig. 4. Major predicted AMR profiles observed within each low- level genogroup. Yellow circles indicate genogroups where the dominant 
AMR profile exhibits less genetic determinants associated with resistance than the second observed profile, for multiple classes of 
antimicrobials. Red circles indicate genogroups where the dominant AMR profile exhibits more genetic determinants associated with 
resistance for multiple classes of antimicrobials. White circles indicate genogroups with a unique AMR profile. AZM, Azithromycin; 
CEF, cephalosporins; CIP, ciprofloxacin; NA, not applicable; PEN, penicillins; RI, rifampicin; SUL, sulphonamides; TET, tetracycline. dXXX 
indicates decreased susceptibility to the named antibiotic, while rXXX indicates resistance to the named antibiotic.
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Fig. 5. Analysis of N. gonorrhoeae WGS- based genetic clusters at low- resolution level potentially concordant with epidemiological 
link. (a) Genetic cluster isolates’ distribution by collection date, with detailed data of each cluster presented on the right. Each isolate 
colour refers to a specific study, and black lines link the earliest and latest isolate detected. Numbers in parentheses in the figure key 
refer to the study reference. (b) MST (also described in Fig. 2) of all isolates analysed in the present study highlighting WGS genetic 
clusters identified at a conservative threshold of 1.5 % AD. Nodes (which represent a unique allelic profile) presenting an allelic distance 
below 40, corresponding to the low- level genogroup threshold, have been collapsed for visualization purposes. The letters within (b) 
represent the following: a, WGSCL0025 Sheffield outbreak described in [34]; b, WGSCL0021 including cluster ST2400 described in [39] 
and the ST2400 MSM- associated isolates described in [6]; c. WGSCL0028 North- East England outbreak described in [39]; d, WGSCL0024 
clade 2 described in [35]; e, WGSCL0023 Leeds outbreak [20] plus clade 1 and 3 described in [35]; f, WGSCL0011 large cluster ST2992 
described in [39]; g, WGSCL0034 cluster ST26 described in [39]; h, WGSCL0029 cluster ST292 described in [39]; i and j, WGSCL0019 and 
WGSCL0020 London outbreaks described in [34]; k, WGSCL0041 small cluster ST2992 described in [39]; l, WGSCL0003 cluster ST1407, 
which includes linked isolates from Brighton and London described in [39], and isolates described as cephalosporin resistant in [6]; m, 
WGSCL0032, the ST4995 MSM- associated isolates described in [6].
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analysis also highlighted genogroups disseminated at multi- 
country level with potential regional transmission chains. For 
instance, G015.016, which is composed by isolates from ten 
different countries, was fragmented into eight smaller genetic 
clusters with only two clusters presenting isolates from 
distinct countries. We also examined each cluster in a time 
scale by each isolate’s collection date (Fig. 5a), which allowed 
us to discriminate between clusters that potentially circu-
lated within a specific time interval (and have not since been 
detected) from clusters that potentially emerged and others 
that are still circulating, even though this is reliant on the 
dataset and time period analysed. For example, WGSCL0025 
(G007.008, mean AD 1.6 %) that enrols isolates spanning 5 
years (1995 up to 2000) seems not to have been detected since, 
which relates to a described outbreak in Sheffield, UK [34]. 
This was also the case for WGSCL0044 (G019.022, mean AD 
1.5 %) with isolates from 2005 up to 2009 and WGSCL0030 
(G012.013, mean AD 1.6 %) with isolates from 2003 up to 
2009 (Fig. 5a), although these did not have a described epide-
miological link as they contained PT isolates and isolates from 
the UK [34]. In contrast, WGSCL0024 (G001.005, mean AD 
1.5 %) and WGSCL0022 (G006.007, mean AD 1.9 %) were 
composed by isolates that have been consistently detected 
from 2004 up to 2017 (the latest year within the dataset). 
Regarding clusters enriched by PT isolates, this could be 
observed for instance in WGSCL0020 (G005.004, mean AD 
1.6 %) with isolates from 2004 up to 2014, in WGSCL0042 
(G001.014, mean AD 1.0 %), a more recent cluster dating 
from 2013 up to 2017, and WGSCL0001, from 2011 up to 
2017. However, we believe that more genomic data is needed 
in order to reinforce these observations as they rely on the 
analysed database; for instance, data from the 2013 EURO- 
GASP survey [6] are a sub- sample restricted to the latter 
months of the year. Nevertheless, a relationship between the 
observed genetic clusters at this threshold and published data 
was clearly observed (Fig.  5). Eleven distinct subsets that 
were phylogenetically related (i.e. epidemiological verified 
outbreaks or verified transmission chains) were consistent 
with the obtained genetic clusters at a threshold of 1.5 %. 
This was the case for: WGSCL0028 (G003.006, mean AD 
1.4 %), an outbreak in North- East England [39]; WGSCL0023 
(G001.005, mean AD 0.8 %), an outbreak of high- resistance 
azithromycin isolates in Leeds [20] linked to isolates from 
other published data [35]; and WGSCL0020, an outbreak 
in London [34], which could be linked to 49 PT isolates, 19 
isolates from the EURO- GASP 2013 survey [6], 51 isolates 
from Brighton [39] and 2 isolates from The Netherlands 
[37]. Of note, one PT isolate (NGPT15194) could be linked 
to the described high- resistance azithromycin N. gonorrhoeae 
isolates in Ireland and the UK (WGSCL0024), with sustained 
transmission [35].
DISCUSSION
In the present study, we aimed to perform a comprehensive 
N. gonorrhoeae genogrouping, based on WGS data, for 
prospective WGS- based laboratory surveillance. Focused on 
the European panorama, we quantitatively evaluated cluster 
stability to identify the major circulating WGS- genogroups, 
assessed their geographical spread, and searched for potential 
relationships between particular genogroups and specific 
AMR signatures. To achieve this, we relied on a recently 
described method (nAWC) [40, 54] to unprecedently analyse 
cluster- partitioning concordance at all possible allelic distance 
thresholds for gonococci. Two cluster- stability points could 
be identified, which enabled the classification of isolates 
into hierarchical WGS- based genogroups. This assignment 
facilitates the assessment (and continuous monitoring) of the 
frequency, geographical dispersion and potential association 
with specific AMR signatures of N. gonorrhoeae circulating 
genogroups, while providing a comprehensive analysis of the 
genetic diversity of this bacterium. Our approach resulted 
in the identification of 180 high- level and 321 low- level 
genogroups, several of which were composed by a single 
isolate or are represented by isolates from a single country. 
Both reflected the global genetic diversity and spread of 
N. gonorrhoeae, and showed the more prevalent and wide-
spread strains circulating in Europe (Fig.  2). At least 5 
high- level genogroups (Table 1) were found in more than 15 
European countries, and 11 low- level genogroups (Table 2) 
were found in at least 6 countries (of which 3 are composed 
by at least 5 isolates). In an opposite scenario, we observed 
81 genogroups that were composed by isolates from a single 
country (Fig. S5). Although N. gonorrhoeae infections lack 
a geographical structure, as revealed by its intercontinental 
spread [39, 61], our results also sustained the existence of 
N. gonorrhoeae transmission chains, likely confined at 
country/regional level. Nevertheless, as WGS is becoming 
more accessible and the several gonococcal antimicrobial 
surveillance programmes are starting to generate substan-
tial genomic data, we cannot discard that the inclusion of 
genomes from other continents may impact the genetic diver-
sity landscape observed in this Europe- oriented study. This 
impact could be reflected in either the addition of entirely new 
genogroups or, for instance, the potential merger of geno-
groups with poorly represented genetic diversity (i.e. repre-
sented here by one or two isolates). In fact, several studies 
have pointed- out a contrasting genetic diversity in countries 
from other continents [27], such as Kenya [62], Canada 
[25, 26], Japan [63], New Zealand [64], Australia [65] or the 
USA [66]. Comparison of typing data showed that the novel 
defined genogroups were mostly populated by a dominant 
MLST or NG- MAST ST (being especially relevant for typing 
comparability), which largely facilitates backwards compat-
ibility and data communication in the transition to WGS- 
based typing (Fig. 1, Table 2). This observation is essential, 
as previous surveillance studies report particular NG- MAST 
genogroups or ST that not only need to be monitored but 
also display relationships with AMR profiles that cannot be 
dismissed [6]. Additionally, our study also showed that the 
quantitatively identified thresholds (4.97 and 9.61 % AD; 40 
and 79 ADs in 822 loci, respectively), reflecting the earliest 
cluster stability (i.e. stable points with maximum resolution), 
provide a higher discriminatory resolution than the recently 
described PubMLST core- genome grouping threshold (400 
ADs in 1649 loci) [28] (Fig. S4). The observed huge cluster 
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agreement at the same threshold reinforces the likelihood that 
the robustness of the clustering will be kept if our high- and 
low- level thresholds are scaled to the entire PubMLST loci 
scheme.
Here, we observed that several WGS- based genogroups seem 
to be associated with distinct profiles of AMR (Figs 3 and 4). 
In fact, one such genogroup was NG- MAST G1407 (identi-
fied as genogroup G002.001 in the present study), which has 
been detected worldwide [27, 66–71] and is one of the major 
types found across Europe [6, 72]. Most isolates from this 
genogroup have been shown to be associated with multidrug 
resistance, presenting resistance or an increased MIC (or 
both) to cefixime, ceftriaxone, azithromycin and ciprofloxacin 
[6, 72, 73]. Concordantly, genetic alterations with potential 
association with cephalosporin resistance [6, 73], i.e. simul-
taneous carriage of mutations 312M, 316T and 545S in penA 
(mainly represented by the penA- XXXIV allele [58]), were 
mostly observed in isolates from this genogroup. Although, 
we detected potential horizontal acquisition of this specific 
penA allele by isolates with different genome backgrounds 
(eight other genogroups). However, it is worth noting that 
all 102 PT isolates belonging to G002.001 (including 87 
harbouring the penA- XXXIV allele) had low MIC values for 
both cefixime and ceftriaxone, whether or not belonging to 
NG- MAST 1407; thus, challenging the association between 
these mutations in NG- MAST G1407 and resistance to cepha-
losporins. This also highlights the fact that some mechanisms 
of resistance in N. gonorrhoeae are still not fully disclosed, and 
further research is needed to understand the linkage between 
resistance and the simultaneous carriage of genetic AMR 
determinants, namely the role of epistatic interactions on 
the level of antimicrobial susceptibility (i.e. differential MIC 
values). For instance, the first cephalosporin- resistant isolate 
detected in Portugal (end of 2019) revealed a single alteration 
(542S) in penA, while presenting MICs of 0.19 and 0.38 mg l−1 
to ceftriaxone and cefixime, respectively [14]. Another geno-
group that warrants particular attention is G001.005, where 
the carriage of the azithromycin- resistance- associated muta-
tion A2045G was mostly observed. This genogroup enrolled 
the isolates associated with high- level azithromycin resistance 
that have been linked to an outbreak in the UK [20, 35]. Of 
note, we found a high- level azithromycin- resistant PT isolate 
that was closely related to other resistant isolates from Ireland 
[36, 38] and the UK [35] (WGCL0024), suggesting its poten-
tial spread.
Overall, two distinct sets of genogroups displaying a 
contrasting pattern of AMR could be observed, i.e. one set 
with isolates carrying several genetic determinants related 
with decreased susceptibility and resistance, and another 
set mostly involving susceptible isolates (Fig.  3). For the 
vast majority of genogroups, we observed a dominant AMR 
profile (of note, for nine genogroups, a single AMR profile 
was observed) and a lower fraction of one or more additional 
AMR profiles (Fig. 4). Since a predominant circulating geno-
group may not be the one carrying an alarming AMR profile, 
the combination of these results may help prioritize which 
genogroups need to be subjected to more close surveillance, 
management and control at both country and continent 
levels. Our results showed that, for some genogroups, the less 
frequently observed AMR profile was the one carrying a larger 
arsenal of genetic determinants for resistance, suggesting the 
potential emergence of novel resistant isolates within a WGS 
subtype. Of note, we detected genogroups where the domi-
nant profile was the one associated with a larger repertoire 
of AMR determinants. This suggests a progressive accumu-
lation of AMR determinants within these genogroups due 
to intensive antibiotic- driven selective pressures, although 
other scenarios cannot be discarded and warrant investiga-
tion (such as the presence of naturally resistant lineages). 
This information may be crucial for surveillance towards the 
identification of evolving strains whose emergence needs to 
be alerted to public- health authorities in order to control a 
local or cross- border spread in early stages.
The strategy described in the present study benefits from the 
comprehensive definition of WGS subtypes for long- term 
surveillance (with backwards compatibility) and a conserva-
tive threshold range that can be used for contact tracing and 
outbreak investigation. While for long- term surveillance, the 
goal is usually to continuously record the bacterial types that 
are circulating in a particular geographical area, for outbreak 
investigation a genomic analysis with higher resolution is 
required, potentiating the identification of shared genomic 
signatures to infer transmission [40, 61]. Defining clusters 
composed of likely related isolates by using specific thresholds 
ranges is an important step in the application of any subtyping 
scheme, but optimizing these thresholds/parameters has been 
a recurring challenge in the field of molecular epidemiology 
[40, 74]. In our approach, we cannot discard that adjusting 
these thresholds and maximizing the dataset may affect cluster 
composition and stability, even though our results are highly 
concordant with previous observations (Figs 2 and 5). None-
theless, this study provides a comprehensive genome- scale 
snapshot of the genetic diversity of circulating N. gonorrhoeae 
strains in Europe. Results suggest that the applied conserva-
tive threshold for potential epidemiological linkage may be 
suitable to highlight clusters for fine- tuned analysis that could 
promote an epidemiological investigation, as cluster composi-
tion at this level seems to match with previous reports on 
outbreaks or transmission chains (Fig. 5). Additionally, the 
possibility to expand the number of loci under analysis in the 
scheme not only allows the performance of a dynamic analysis 
of epidemiological clusters, but also increases the confidence 
in results, as the link between strains is strengthened when AD 
decreases or remains unaltered after generating a sub- MST 
with a higher number of shared loci (Fig. 5). This concept of 
dynamically reconstructing phylogenies for sub- sets of strains 
(by maximizing the number of shared loci) and the bioin-
formatics tools needed for its operationalization were set- up 
recently for foodborne pathogens [40] and were applied to 
respiratory pathogens [75], showing that they facilitate the 
use of WGS in routine surveillance and, consequently, epide-
miological investigations.
Ultimately, in the frame of the demanding short- term 
transition from traditional genotyping methods, the 
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current comparative study is an important step towards 
the implementation of a WGS- based laboratory workflow 
for N. gonorrhoeae surveillance in the NRL. The laboratory 
surveillance and isolates collection built up on behalf of 
PTGonoNet, hosted at the NRL [31], has already strength-
ened our contribution to the EURO- GASP [6]. This has 
been achieved through the enrichment of the current geo- 
temporal and genomic diversity of N. gonorrhoeae, by adding 
WGS data of isolates spanning 15 years of N. gonorrhoeae 
surveillance in Portugal. Together with the centralization of 
the AMR phenotypic characterization and molecular typing 
at the Portuguese National Institute of Health, and a strong 
articulation with the public- health authorities, the framework 
described should constitute the driving force towards a faster 
and robust prospective surveillance of cases, from antibiotic- 
resistance prediction to transmission- chain detection. Future 
studies based on this approach will be crucial to consolidate 
the benefits of this technological transition for public health 
through the prioritization of genogroups to be monitored, 
the identification of emerging resistance carriage, and the 
potential facilitation of data sharing and communication.
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